Insiders Trades
RT
RELIEF THERAPEUTICS Holding AG Stock: price and insider trades · Switzerland
RELIEF THERAPEUTICS Holding AG: what insiders have been doing
RELIEF THERAPEUTICS Holding AG, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SIX SER. 3 insiders have disclosed 13 filings since 18 October 2025.
All open-market trades in the period are sales: 13 sales worth €1.4M, by 3 insiders, with no purchase on record. The largest single trade was a sale of €441k, published on 15 December 2025.
Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Across the 178 companies tracked on its exchange, the median is 9 filings; at 13 filings, this issuer sits above that mark. Our records for RELIEF THERAPEUTICS Holding AG go back to 2024, with no purchases and 51 sales on the open market in total.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from SIX SER. Past trades are no guide to future returns.
Insider Decl.
51
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€2M
51 ops. · all time
Who traded when
BuySaleAnonymous (Executive member of the board of directors / member of senior management)35 sales
Anonymous (Non-executive member of the board of directors)15 sales
Anonymous (a non-executive member of the board of directors)1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,923 of 24,148 companies
28.8
score / 100
Value7
Quality51
FCF yld-29%
Earn yld-40%
EV/EBITDA·
ROE-52%
Gross mgn92%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CHF 0.15
Analyst consensus
1 analystsCHF 2.73Target CHF 2.73(+1760%)CHF 2.73
Income statement
RevenueCHF 642k
Gross profitCHF 591k92% margin
EBITDA-CHF 8M-1246% margin
Net income-CHF 9.9M-1543.0% margin
Valuation
PER (forward)1.0x
P/Book0.7x
Balance sheet & cash
Market capCHF 25M
Total debtCHF 1.8M
Free Cash Flow-CHF 7.2M
Debt / Equity0%
Profitability & ownership
ROE-51.6%
ROA-25.5%
% insiders50.3%
% institutions18.6%
Last declaration on 14 September 2026
Declarations51 total
60,000 shares@ CHF 0.170.042% mcap100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9E00075
49,000 shares@ CHF 1.25734.6% of flowISIN CH1251125998SIX:T1Q1J00055
100,000 shares@ CHF 1.584211.9% of flowISIN CH1251125998SIX:T1Q1500032
65,000 shares@ CHF 2.2511.0% of flowISIN CH1251125998SIX:T1PCN00090
69,000 shares@ CHF 2.210211.4% of flowISIN CH1251125998SIX:T1PCM00092
37,000 shares@ CHF 2.68487.5% of flowISIN CH1251125998SIX:T1PCJ000A3
140,000 shares@ CHF 1.650117.3% of flowISIN CH1251125998SIX:T1PCG000A6
52,162 shares@ CHF 1.054.1% of flowISIN CH1251125998SIX:T1PCG00094
281,968 shares@ CHF 1.461230.8% of flowISIN CH1251125998SIX:T1PCF000B5
▼
Anonymous (Executive member of the board of directors / member of senior management)
600 shares@ CHF 2.950.2% of flowISIN CH1251125998SIX:T1PB600060
▼
Anonymous (Executive member of the board of directors / member of senior management)
5,000 shares@ CHF 2.98431.7% of flowISIN CH1251125998SIX:T1PB400065
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 3.0650.3% of flowISIN CH1251125998SIX:T1PAV000D3
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,200 shares@ CHF 3.11130.4% of flowISIN CH1251125998SIX:T1PAU00099
▼
Anonymous (Executive member of the board of directors / member of senior management)
3,000 shares@ CHF 2.74310.9% of flowISIN CH1251125998SIX:T1PAE00085
▼
Anonymous (Executive member of the board of directors / member of senior management)
6,000 shares@ CHF 2.79641.9% of flowISIN CH1251125998SIX:T1PAD00053
▼
Anonymous (Executive member of the board of directors / member of senior management)
9,000 shares@ CHF 2.97053.0% of flowISIN CH1251125998SIX:T1PAA00067
7,500 shares@ CHF 1.520.9% of flowISIN CH1251125998SIX:T1PA900057
▼
Anonymous (Executive member of the board of directors / member of senior management)
6,000 shares@ CHF 3.45172.3% of flowISIN CH1251125998SIX:T1PA900065
5,000 shares@ CHF 0.6650.2% of flowISIN CH1251125998SIX:T1P8J00093
3,500 shares@ CHF 0.6650.2% of flowISIN CH1251125998SIX:T1P8I000B1
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,500 shares@ CHF 2.17930.6% of flowISIN CH1251125998SIX:T1P6600094
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,000 shares@ CHF 2.25560.5% of flowISIN CH1251125998SIX:T1P6500070
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,000 shares@ CHF 2.27690.5% of flowISIN CH1251125998SIX:T1P64000D5
▼
Anonymous (Executive member of the board of directors / member of senior management)
3,500 shares@ CHF 2.3250.9% of flowISIN CH1251125998SIX:T1P6300034
▼
Anonymous (Executive member of the board of directors / member of senior management)
8,000 shares@ CHF 2.35782.1% of flowISIN CH1251125998SIX:T1P5U000C6
25 of 51 declarations
About RELIEF THERAPEUTICS Holding AG
RELIEF THERAPEUTICS Holding AG is a Swiss company focused on developing treatments for rare diseases and neurological disorders. It is listed on the Swiss stock exchange XSWX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
